$3.24
0.299.83%
At close: Sep 4, 5:00 PM EST
$3.30
0.061.85%
After Hours: Sep 4, 7:08 PM EST

Quantum BioPharma (QNTM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.51 | $-0.56 | $-0.93 | $-0.08 |
| Actual | $-0.47 | $-3.06 | $-0.71 | $-1.25 |
| Surprise | +7.84% | -446.4% | +23.7% | -1462.5% |
| Revenue | ||||
| Estimate | — | $1.5M | $1.2M | $1.9M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | -100.0% | -100.0% | -100.0% |
| Metric | Q3 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.63 |
| Revenue | |
| Consensus | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.47 | $-0.51 | 7.84 % |
| Q1 | May 6, 2026 | $-3.06 | $-0.56 | -446.4 % |
| Q4 | Mar 26, 2026 | $-0.71 | $-0.93 | 23.7 % |
| Q3 | Nov 7, 2025 | $-1.25 | $-0.08 | -1462.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 6, 2026 | $0 | $1.50M | -100.0 % |
| Q4 | Mar 26, 2026 | $0 | $1.16M | -100.0 % |
| Q3 | Nov 7, 2025 | $0 | $1.90M | -100.0 % |
| Q2 | Aug 7, 2025 | $0 | $2.89M | -100.0 % |